Reply to G.B. Holt
J Clin Oncol
.
2016 Mar 20;34(9):1016-7.
doi: 10.1200/JCO.2015.65.3782.
Epub 2016 Jan 11.
Authors
Alexi A Wright
1
,
Angel Cronin
2
,
David M O'Malley
3
Affiliations
1
Dana-Farber Cancer Institute and Brigham and Women's Cancer Center, Boston, MA alexi_wright@dfci.harvard.edu.
2
Dana-Farber Cancer Institute and Brigham and Women's Cancer Center, Boston, MA.
3
The Ohio State University Comprehensive Cancer Center, Columbus, OH.
PMID:
26755516
DOI:
10.1200/JCO.2015.65.3782
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Antineoplastic Agents / administration & dosage*
Female
Humans
Ovarian Neoplasms / drug therapy*
Substances
Antineoplastic Agents
Grants and funding
K07 CA166210/CA/NCI NIH HHS/United States